# Northpointe Bancshares Inc: financial statements, quarterly

NPB · NYSE · CIK 1336706 · [Financials](/sectors/financials.md)

Pages: [Overview](/companies/npb.md) · [Financials](/companies/npb/financials.md) · [Filings](/companies/npb/filings.md) · [Insiders](/companies/npb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/npb/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $m | [4.0](/filings/0001628280-25-025977.md) | [4.2](/filings/0001336706-25-000004.md) | [5.9](/filings/0001336706-25-000008.md) | [3.7 d](/filings/0001336706-26-000020.md) | [5.3](/filings/0001336706-26-000044.md) | [6.3](/filings/0001336706-26-000064.md) | [7.0](/filings/0001336706-25-000008.md) | [8.3 d](/filings/0001336706-26-000020.md) | [7.3](/filings/0001336706-26-000044.md) | [7.1](/filings/0001336706-26-000064.md) |
| Net income | $m | [12.3](/filings/0001628280-25-025977.md) | [13.2](/filings/0001336706-25-000004.md) | [18.7](/filings/0001336706-25-000008.md) | [11.0 d](/filings/0001336706-26-000020.md) | [17.2](/filings/0001336706-26-000044.md) | [20.3](/filings/0001336706-26-000064.md) | [22.2](/filings/0001336706-25-000008.md) | [23.6 d](/filings/0001336706-26-000020.md) | [22.2](/filings/0001336706-26-000044.md) | [21.7](/filings/0001336706-26-000064.md) |
| Diluted EPS | $ per share | [0.38](/filings/0001628280-25-025977.md) | [0.44](/filings/0001336706-25-000004.md) | [0.66](/filings/0001336706-25-000008.md) | not reported | [0.49](/filings/0001336706-26-000044.md) | [0.51](/filings/0001336706-26-000064.md) | [0.57](/filings/0001336706-25-000008.md) | not reported | [0.62](/filings/0001336706-26-000044.md) | [0.60](/filings/0001336706-26-000064.md) |
| Basic EPS | $ per share | [0.38](/filings/0001628280-25-025977.md) | [0.44](/filings/0001336706-25-000004.md) | [0.67](/filings/0001336706-25-000008.md) | not reported | [0.50](/filings/0001336706-26-000044.md) | [0.52](/filings/0001336706-26-000064.md) | [0.58](/filings/0001336706-25-000008.md) | not reported | [0.63](/filings/0001336706-26-000044.md) | [0.61](/filings/0001336706-26-000064.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [352](/filings/0001628280-25-015483.md) | not reported | not reported | not reported | [376](/filings/0001336706-26-000020.md) | [321](/filings/0001628280-25-025977.md) | [416](/filings/0001336706-25-000004.md) | [419](/filings/0001336706-25-000008.md) | [496](/filings/0001336706-26-000064.md) | [488](/filings/0001336706-26-000044.md) | [538](/filings/0001336706-26-000064.md) |
| Total assets | $m | not reported | [4,758](/filings/0001628280-25-015483.md) | [4,865](/filings/0001628280-25-025977.md) | [5,224](/filings/0001336706-25-000004.md) | [5,386](/filings/0001336706-25-000008.md) | [5,224](/filings/0001336706-26-000020.md) | [5,860](/filings/0001336706-26-000044.md) | [6,431](/filings/0001336706-26-000064.md) | [6,840](/filings/0001336706-25-000008.md) | [7,023](/filings/0001336706-26-000064.md) | [7,396](/filings/0001336706-26-000044.md) | [7,530](/filings/0001336706-26-000064.md) |
| Total liabilities | $m | not reported | [4,328](/filings/0001628280-25-015483.md) | not reported | not reported | not reported | [4,762](/filings/0001336706-26-000020.md) | [5,273](/filings/0001628280-25-025977.md) | [5,827](/filings/0001336706-25-000004.md) | [6,216](/filings/0001336706-25-000008.md) | [6,454](/filings/0001336706-26-000064.md) | [6,806](/filings/0001336706-26-000044.md) | [6,918](/filings/0001336706-26-000064.md) |
| Shareholders' equity | $m | [417](/filings/0001628280-25-015483.md) | [431](/filings/0001336706-26-000020.md) | [440](/filings/0001336706-25-000004.md) | [446](/filings/0001336706-25-000008.md) | [455](/filings/0001336706-25-000008.md) | [462](/filings/0001336706-26-000064.md) | [587](/filings/0001336706-26-000064.md) | [604](/filings/0001336706-26-000064.md) | [624](/filings/0001336706-25-000008.md) | [569](/filings/0001336706-26-000064.md) | [590](/filings/0001336706-26-000064.md) | [612](/filings/0001336706-26-000064.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.9)](/filings/0001628280-25-025977.md) | [(33.9) d](/filings/0001336706-25-000004.md) | [45.1 d](/filings/0001336706-25-000008.md) | [9.6 d](/filings/0001336706-26-000020.md) | [54.4](/filings/0001336706-26-000044.md) | [(72.3) d](/filings/0001336706-26-000064.md) | [90.4 d](/filings/0001336706-25-000008.md) | [(28.3) d](/filings/0001336706-26-000020.md) | [37.7](/filings/0001336706-26-000044.md) | [3.9 d](/filings/0001336706-26-000064.md) |
| Capital expenditure | $m | [0.6](/filings/0001628280-25-025977.md) | [(0.0) d](/filings/0001336706-25-000004.md) | [0.4 d](/filings/0001336706-25-000008.md) | [0.1 d](/filings/0001336706-26-000020.md) | [0.3](/filings/0001336706-26-000044.md) | [1.1 d](/filings/0001336706-26-000064.md) | [0.8 d](/filings/0001336706-25-000008.md) | [0.5 d](/filings/0001336706-26-000020.md) | [0.4](/filings/0001336706-26-000044.md) | [0.2 d](/filings/0001336706-26-000064.md) |
| Dividends paid | $m | [0.6](/filings/0001628280-25-025977.md) | [0.6 d](/filings/0001336706-25-000004.md) | [0.6 d](/filings/0001336706-25-000008.md) | [0.6 d](/filings/0001336706-26-000020.md) | [0.6](/filings/0001336706-26-000044.md) | [0.9 d](/filings/0001336706-26-000064.md) | [0.9 d](/filings/0001336706-25-000008.md) | [0.9 d](/filings/0001336706-26-000020.md) | [0.9](/filings/0001336706-26-000044.md) | [0.9 d](/filings/0001336706-26-000064.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.8](/filings/0001628280-25-025977.md) | [25.8](/filings/0001336706-25-000004.md) | [25.8](/filings/0001336706-25-000008.md) | [30.4](/filings/0001336706-26-000044.md) | [35.2](/filings/0001336706-26-000064.md) | [35.3](/filings/0001336706-25-000008.md) | [35.3](/filings/0001336706-26-000044.md) | [35.4](/filings/0001336706-26-000064.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 34,581,842 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001336706-26-000064.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.